Z-2746-2026 Class II Ongoing

Recalled by Tosoh Bioscience Inc — Grove City, OH

FDA device recall Z-2746-2026 was initiated by Tosoh Bioscience Inc on Jun 12, 2026 and is designated Class II. Reason for recall: The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low… The recall status is ongoing. Affected quantity: 310 units.

Recall details

Product Type
Devices
Report Date
Jul 22, 2026
Initiation Date
Jun 12, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
310 units

Product description

ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone in human serum on specific Tosoh AIA System analyzers, Model Number 0025204

Reason for recall

The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone results. Such erroneous test results may lead to additional testing/diagnostic interventions and in limited cases, may lead to a delay in diagnosis and/or initiation of unnecessary or incorrect clinical treatment measures.

Distribution pattern

Global Distribution. US Nationwide.

Code information

UDI-DI: 14560189210032; Lot Numbers: FX12404, FY12407, FY12406, FZ12408

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2746-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2746-2026. Report a data issue: hello@regdatalab.com.